Myositis-related interstitial lung disease - a systemic autoimmune desease often overlooked
Interstitial lung disease can be the first sign of systemic autoimmune disease. If associated with myositis, interstitial lung disease may be the only symptom, with no presence of muscular weakness or other extramuscular manifestations. ANA-testing performed with indirect immune fluorescence may be negative. Testing for myositis antibodies should be considered as a step in the diagnostic process when strong clinical suspicion of interstitial lung disease of unknown origin is present. If interstitial lung disease is suspected, the patients should be referred to a specialist clinic for further investigation and, if possible, for discussion within a multidisciplinary team. Early suspicion of systemic inflammatory disease, rapid diagnosis and early start of treatment are crucial for future prognosis, quality of life and survival.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:119 |
|---|---|
| Enthalten in: |
Lakartidningen - 119(2022) vom: 08. Aug. |
| Sprache: |
Schwedisch |
|---|
| Weiterer Titel: |
Interstitiell lungsjukdom med myositantikroppar ofta förbisedd |
|---|
| Beteiligte Personen: |
Lodin, Karin [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.09.2022 Date Revised 13.09.2022 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM345999800 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345999800 | ||
| 003 | DE-627 | ||
| 005 | 20231226030404.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||swe c | ||
| 028 | 5 | 2 | |a pubmed24n1153.xml |
| 035 | |a (DE-627)NLM345999800 | ||
| 035 | |a (NLM)36082925 | ||
| 035 | |a (PII)22023 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a swe | ||
| 100 | 1 | |a Lodin, Karin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myositis-related interstitial lung disease - a systemic autoimmune desease often overlooked |
| 246 | 3 | 3 | |a Interstitiell lungsjukdom med myositantikroppar ofta förbisedd |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.09.2022 | ||
| 500 | |a Date Revised 13.09.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Interstitial lung disease can be the first sign of systemic autoimmune disease. If associated with myositis, interstitial lung disease may be the only symptom, with no presence of muscular weakness or other extramuscular manifestations. ANA-testing performed with indirect immune fluorescence may be negative. Testing for myositis antibodies should be considered as a step in the diagnostic process when strong clinical suspicion of interstitial lung disease of unknown origin is present. If interstitial lung disease is suspected, the patients should be referred to a specialist clinic for further investigation and, if possible, for discussion within a multidisciplinary team. Early suspicion of systemic inflammatory disease, rapid diagnosis and early start of treatment are crucial for future prognosis, quality of life and survival | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 700 | 1 | |a Notarnicola, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Dastmalchi, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Dani, Lara |e verfasserin |4 aut | |
| 700 | 1 | |a Mari Svensson, Ann |e verfasserin |4 aut | |
| 700 | 1 | |a Rönnelid, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Sköld, Magnus |e verfasserin |4 aut | |
| 700 | 1 | |a E Lundberg, Ingrid |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lakartidningen |d 1965 |g 119(2022) vom: 08. Aug. |w (DE-627)NLM000007544 |x 1652-7518 |7 nnns |
| 773 | 1 | 8 | |g volume:119 |g year:2022 |g day:08 |g month:08 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 119 |j 2022 |b 08 |c 08 | ||